| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/11/2012 | EP2403516A1 Antagonistic peptides for frizzled-1 and frizzled-2 |
| 01/11/2012 | EP2403515A2 Compositions and methods |
| 01/11/2012 | EP2403514A1 Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects |
| 01/11/2012 | EP1948215B1 MacroH2A non-histone domain as inhibitor of PARP-1 activity and uses thereof |
| 01/11/2012 | EP1885392B1 Insulins combinations |
| 01/11/2012 | EP1608399B1 Complex of sclerostin and noggin or chordin, and agents that modulate the formation of said complex |
| 01/11/2012 | EP1565210B1 Clostridial neurotoxin for use in the treatment of nasal congestion |
| 01/11/2012 | EP1483384B1 Method for overexpression of zwitterionic polysaccharides |
| 01/11/2012 | EP1468092B1 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 01/11/2012 | EP1448593B1 Alpha-fetoprotein peptides and uses thereof |
| 01/11/2012 | EP1438586B1 Fret protease assays for clostridial toxins |
| 01/11/2012 | EP1402070B1 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 01/11/2012 | EP1019432B1 The ob receptor and methods of diagnosing and treating weight |
| 01/11/2012 | EP0975672B1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 01/11/2012 | CN1997385B Annexin V for preventing atherothrombois and plaque rupture |
| 01/11/2012 | CN102317320A Fusion protein capable of binding VEGF-A and TNF-alpha |
| 01/11/2012 | CN102317313A Production and uses of type 1 ribosome inactivating proteins |
| 01/11/2012 | CN102317311A Novel peptides and methods for producing them |
| 01/11/2012 | CN102317257A Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| 01/11/2012 | CN102316935A Therapeutic regimen comprising peg- interferon, ribavirin and VX-950 for the treatment of hepatitis |
| 01/11/2012 | CN102316893A Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents |
| 01/11/2012 | CN102316892A Use of cardiotrophin- 1 for the treatment of metabolic diseases |
| 01/11/2012 | CN102316891A Use of G-CSF for the extension of the therapeutic time-window of thrombolytic stroke therapy |
| 01/11/2012 | CN102316890A Bone grafts with reduced protease activity and methods of selection and use |
| 01/11/2012 | CN102316889A Compositions containing satiogens and methods of use |
| 01/11/2012 | CN102316888A Modulation of synaptogenesis |
| 01/11/2012 | CN102316887A Compositions and methods to prevent cancer with cupredoxins |
| 01/11/2012 | CN102316886A Skin aging-inhibiting peptide |
| 01/11/2012 | CN102316885A Method of inhibiting clostridium difficile by administration of oritavancin |
| 01/11/2012 | CN102316731A Cell-permeant peptide-based inhibitor of kinases |
| 01/11/2012 | CN102311957A Hydatidovis soluble antigen preparation method and product thereof |
| 01/11/2012 | CN102311951A Constitutive expression cassette of Trichoderma reesei, expression vector, and recombinant strain and application thereof |
| 01/11/2012 | CN102311503A Recombinant human serum albumin / FGF fusion protein with continuous effect on restoration of a plurality of skin cells |
| 01/11/2012 | CN102311502A Fusion protein used for inhibiting regeneration or growth of blood vessel and medical treatment application thereof |
| 01/11/2012 | CN102311501A Fusion protein comprising GLP-1 (Glucagon-Like Peptide) or analog thereof and preparation method as well as application thereof |
| 01/11/2012 | CN102311500A Antiviral fusion protein and application thereof |
| 01/11/2012 | CN102311493A Peptide inhibiting telomerase activity, its preparation method and application |
| 01/11/2012 | CN102311492A Non-natural fully D-type snake venom cathelicidin antibacterial peptide and derivative, preparation method as well as application thereof |
| 01/11/2012 | CN102311487A Anti-HIV (Human Immunodeficiency Virus) infection polypeptide, composition and application |
| 01/11/2012 | CN102311485A Polypeptide with neovascularization suppression effect and application thereof |
| 01/11/2012 | CN102311483A Lowly hemolytic antimicrobial lipopeptide and preparation method thereof |
| 01/11/2012 | CN102311482A Aro-peptide and preparation method as well as medicinal combination and application of aro-peptide |
| 01/11/2012 | CN102309765A Long-acting anticoagulant polypeptide including immunoglobulin Fc segments as carriers and preparation method of same |
| 01/11/2012 | CN102309764A Method for aiding polyethylene glycol (PEG) to modify protein medicament by using organic solvent |
| 01/11/2012 | CN102309758A Medicinal composition for treating diseases caused by enterovirus infections |
| 01/11/2012 | CN102309752A Protein related to brain ageing and Alzheimer's disease and application thereof |
| 01/11/2012 | CN102309751A Superoxide dismutase (SOD) composite capsule and preparation method thereof |
| 01/11/2012 | CN102309750A Special conditioning and nourishing film for use at genital of woman |
| 01/11/2012 | CN102309749A Nutritional ointment for treating foot and hand cracks |
| 01/11/2012 | CN102309748A Application of fibronectin N-end and C-end heparin combining domain peptides to preparation of medicament for resisting liver cancer cell invasion and metastasis |
| 01/11/2012 | CN102309747A Composition of glycoprotein scarcely containing subunits |
| 01/11/2012 | CN102309746A Composition of glycoprotein scarcely containing subunits |
| 01/11/2012 | CN102309745A Glycoprotein composition which almost does not contain subunit |
| 01/11/2012 | CN102309744A Composition of glycoprotein contains hardly subunit |
| 01/11/2012 | CN102309743A New purpose of recombinant human thrombopoietin (rhTPO) |
| 01/11/2012 | CN102309742A Application of transcription factor FOXO1 in regulation of specific micro-ribonucleic acid (RNA) miR-122 of human liver |
| 01/11/2012 | CN102309523A Dentoidin sponginum and preparation method thereof |
| 01/11/2012 | CN102309453A Exenatide multivesicular liposome and preparation method thereof |
| 01/11/2012 | CN101935640B Bacterial colony induction signal degrading enzyme and coding gene and application thereof |
| 01/11/2012 | CN101914140B Scorpion source antivirus active polypeptide and application thereof |
| 01/11/2012 | CN101781357B Polypeptide for detecting human cancer cells, and application thereof |
| 01/11/2012 | CN101698678B Silkworm antibacterial peptide, cDNA sequence thereof and application thereof |
| 01/11/2012 | CN101638438B Human epididymis protease profilin immunological contraception polypeptide |
| 01/11/2012 | CN101570569B Synthetic antibacterial peptide and preparation method and application thereof |
| 01/11/2012 | CN101550178B Blood polypeptide and preparation method and application thereof |
| 01/11/2012 | CN101443033B Device for enhancing tissue glucose processing |
| 01/11/2012 | CN101267832B Platelet aggregation inhibitor and health food effective in inhibiting platelet aggregation |
| 01/11/2012 | CN101229366B Applications of fibroblast growth factor on preparing vasculogenesis-promoting medicine |
| 01/11/2012 | CN101189335B Leptin antagonists |
| 01/11/2012 | CN101134106B Pharmaceutical composition containing human urine kininogenase for treating cerebral infarction |
| 01/11/2012 | CN101005828B Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents |
| 01/10/2012 | US8093380 Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infections |
| 01/10/2012 | US8093354 Process for preparing glycopeptide phosphonate derivatives |
| 01/10/2012 | US8093353 Screening compounds which disrupt the association of helices with cytoplasmic membranes |
| 01/10/2012 | US8093300 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 01/10/2012 | US8093224 Antisense modulation of C-reactive protein expression |
| 01/10/2012 | US8093223 RIP140 regulation of diabetes |
| 01/10/2012 | US8093218 Peptide derived from vascular endothelial growth factor receptor-1 binding integrin α5β1 having proangiogenic activity |
| 01/10/2012 | US8093217 For sensitizing multi-drug resistant cancer or radiation resistant cancer cells to chemotherapeutic agents |
| 01/10/2012 | US8093216 Diagnosis and classification of cancer; obtain tissue sample, lyse cells, screen lysate for expression of tumor polypeptide, presence of polypeptide indicates tumor |
| 01/10/2012 | US8093214 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 01/10/2012 | US8093213 Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation |
| 01/10/2012 | US8093212 Methods of treating nerve-related vision disorders by an insulinomimetic agent |
| 01/10/2012 | US8093211 Methods and pharmaceutical compositions for healing wounds |
| 01/10/2012 | US8093210 Treatment of sepsis with 5-ethyl-1-phenyl-2(1H)-pyridone |
| 01/10/2012 | US8093209 Methods of suppressing microglial activation and systemic inflammatory responses |
| 01/10/2012 | US8093207 Fast-acting oral peptide pharmaceutical products |
| 01/10/2012 | US8093206 Methods involving long lasting synthetic exendin-4 peptide conjugates |
| 01/10/2012 | US8093205 Method for treating a stroke by implanting a first therapy delivery element in the CNS and a second therapy delivery element in a damaged tissue of the CNS to promote neurogenesis |
| 01/10/2012 | US8093034 Fed batch culture methods for streptococci |
| 01/10/2012 | US8093013 Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer |
| 01/10/2012 | US8092834 Zinc oxide-covering silica, -talc and/or -mica; complex powder comprising enzyme adsorption and operation sites |
| 01/10/2012 | US8092833 Compositions containing inclusion complexes |
| 01/10/2012 | US8092823 Osteogenic implants with combined implant materials and methods for same |
| 01/10/2012 | US8092820 Dry hemostatic compositions and methods for their preparation |
| 01/10/2012 | US8092818 Medical devices having bioactive surfaces |
| 01/10/2012 | US8092807 Modified leukocyte Ig-like receptor family members (LIRs) with increased affinity for class 1 MHC and their uses in modulating T-cell activation |
| 01/10/2012 | US8092806 Chimeric proteins, their preparation and pharmaceutical compositions containing them |
| 01/10/2012 | US8092805 Dual inhibitors of HIV-1 gp-120 interactions |
| 01/10/2012 | US8092803 VEGF antagonist formulations for intravitreal administration |